Background Insulinomas are rare tumours. Their clinical presentation, localization
techniques and operative management were reviewed. Methods An electronic search of the …

Tissue acquisition using EUS has considerably evolved since the first EUS-FNA was
reported 25 years ago. Its introduction was an important breakthrough in the endoscopic …

BACKGROUND:: The role of EUS for detection of pancreatic neuroendocrine tumors
(PNETs) is not clearly defined in institutions that use multidetector CT for pancreatic imaging …

The role of endoscopic ultrasound (EUS) in the evaluation of entero-pancreatic endocrine
tumours has evolved in conjunction with advances in other imaging methods. The high …

Pancreatic neuroendocrine neoplasms (PanNENs) are relatively rare, but their incidence
has increased significantly in the last decades. Precise diagnosis and prognostic …

BACKGROUND: The use of EUS for precise preoperative evaluation of pancreatic
neuroendocrine tumors is well established; up to 80% of insulinomas can be localized …

Insulinomas continue to pose a diagnostic challenge to physicians, surgeons and
radiologists alike. Most are intrapancreatic, benign and solitary. Biochemical diagnosis is …

The proximity of the endoscopic ultrasound (EUS) transducer to the pancreas and the
possibility to place needles or other accessories into a target located adjacent to the wall of …

The American Society for Gastrointestinal Endoscopy (ASGE) Technology Committee
provides reviews of existing, new, or emerging endoscopic technologies that have an impact …

BACKGROUND: Pancreatic neuroendocrine tumors (PNTs) are rare tumors with malignant
potential. EUS and EUS-guided FNA (EUS-FNA) have been shown to be superior to other …